|
The PHS 2024-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. The first application due date is Thursday, September 5, 2024, so start preparing your application today.
As usual, there are four Omnibus Solicitations:
-
PA-24-245: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed).
-
PA-24-246: PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required).
-
PA-24-247: PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed).
-
PA-24-248: PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required).
Please note: Section V. Application Review information has been updated, including:
- The peer review criteria have been revised to better address program goals, and for consistency.
- Information about the Review and Selection Process, including the Just-in-Time process and review of Federal Award History, has been consolidated in this section.
As always, applicants are urged to read the solicitations in full and review related notices for relevant policy updates.
Questions? Email us at SEEDinfo@nih.gov.
|
